Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

Mesoblast (MESO) EBT Margin: 2014-2023

Historic EBT Margin for Mesoblast (MESO) over the last 8 years, with Jun 2023 value amounting to -1,026.60%.

  • Mesoblast's EBT Margin fell 5956.00% to -1,026.60% in Q2 2023 from the same period last year, while for Jun 2023 it was -988.81%, marking a year-over-year decrease of 9196.00%. This contributed to the annual value of -592.00% for FY2025, which is 90151.00% up from last year.
  • Latest data reveals that Mesoblast reported EBT Margin of -1,026.60% as of Q2 2023, which was down 6.76% from -961.63% recorded in Q1 2023.
  • In the past 5 years, Mesoblast's EBT Margin registered a high of -43.50% during Q3 2019, and its lowest value of -5,116.55% during Q2 2020.
  • Its 3-year average for EBT Margin is -1,021.26%, with a median of -1,044.06% in 2022.
  • In the last 5 years, Mesoblast's EBT Margin crashed by 390,135bps in 2020 and then soared by 399,516bps in 2021.
  • Mesoblast's EBT Margin (Quarterly) stood at -1,217.27% in 2019, then surged by 7,412bps to -1,143.15% in 2020, then soared by 5,104bps to -1,092.11% in 2021, then plummeted by 5,864bps to -1,150.75% in 2022, then slumped by 5,956bps to -1,026.60% in 2023.
  • Its EBT Margin stands at -1,026.60% for Q2 2023, versus -961.63% for Q1 2023 and -1,150.75% for Q4 2022.